Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.545 USD | +0.55% | -1.20% | +10.32% |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 95.67M |
---|---|---|---|---|---|
Net income 2023 * | -31M | Net income 2024 * | -34M | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-2.89
x | P/E ratio 2024 * |
-3.63
x | Employees | 20 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 90.72% |
Latest transcript on Achieve Life Sciences, Inc.
1 day | -3.00% | ||
1 week | -3.00% | ||
Current month | +11.60% | ||
1 month | +0.44% | ||
3 months | +9.98% | ||
6 months | +5.12% | ||
Current year | +9.71% |
Managers | Title | Age | Since |
---|---|---|---|
John Bencich
CEO | Chief Executive Officer | 47 | 14-07-31 |
Richard Stewart
CHM | Chairman | 65 | 15-04-30 |
Cindy Jacobs
PSD | President | 66 | 08-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 22-03-13 |
Thomas King
BRD | Director/Board Member | 69 | 23-03-28 |
Cindy Jacobs
PSD | President | 66 | 08-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 4.545 | +0.55% | 83 725 |
24-03-27 | 4.52 | -3.00% | 90,371 |
24-03-26 | 4.66 | -0.21% | 70,140 |
24-03-25 | 4.67 | +1.52% | 91,377 |
24-03-22 | 4.6 | 0.00% | 46,633 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.71% | 95.67M | |
+9.16% | 45.97B | |
+54.20% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |